Cartalax Research Peptide Overview
Cartalax is a synthetic tripeptide bioregulator investigated for its interactions with cartilage and connective tissue cellular regulation and gene expression pathways in preclinical models.
Molecular Composition and Mechanistic Profile
Peptide identity: Cartalax is a three amino acid peptide with the sequence Ala Glu Asp (AED).
Origin: Synthetic short regulatory peptide developed from sequences associated with cartilage and connective tissue polypeptides in the bioregulator class.
Mechanistically, Cartalax has been associated with:
Sequence specific interactions with DNA motifs that may influence gene expression related to chondrocytes and matrix components.
Modulation of cellular pathways linked to extracellular matrix synthesis and connective tissue homeostasis in experimental systems.
Effects on proliferation and regulatory markers observed in cartilage associated cell preparations.
These properties position Cartalax as a tool for studying tissue specific bioregulatory signaling in cartilage models.
Integrated Research Applications
Cartalax is examined in systems focused on cartilage and connective tissue regulation. Representative domains include:
Chondrocyte and cartilage models: Investigation of matrix related gene expression and cellular activity markers in cultured cells and animal tissue preparations.
Connective tissue studies: Evaluation of effects on fibroblast and extracellular matrix dynamics in experimental systems.
Gene regulation and DNA interaction research: Assessment of binding preferences and transcriptional influences in laboratory settings.
Comparative bioregulator research: Use alongside related short peptides to explore organ specific regulatory mechanisms in controlled laboratory settings.
Overall, Cartalax serves as a research tool for exploring short peptide modulation of cartilage tissue homeostasis and cellular regulatory networks.
Analytical Validation, Formulation, and Storage
NextGenPeps supplies Cartalax as a high purity research peptide. Typical quality and handling features include:
Purity: ≥99% verified by HPLC.
Formulation: White lyophilized powder in sealed glass vials, intended for reconstitution with appropriate research grade solvent for experimental use only. No dosing guidance is provided for any organism.
Storage: Keep lyophilized material in a cool dark dry environment; long term storage at or below −20 °C. Store reconstituted solutions refrigerated, minimize freeze thaw cycles, and use within laboratory defined stability windows.
These conditions support structural integrity and reproducible experimental outcomes.
NextGenPeps supplies Cartalax as a high purity research peptide intended strictly for controlled laboratory use in vitro or in established animal models, such as murine systems. This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for human consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
